Evidera
Saroj Dhungel, MBA, is an experienced project manager specializing in clinical research and medical imaging. Currently serving as a Project Manager at Evidera since May 2021, Saroj previously held a similar position at Parexel from 2019 to 2021. Prior to that role, Saroj was a Senior Research Associate at Labcorp from 2016 to 2019, focusing on medical device and in-vitro diagnostic development. Saroj's career began as a Molecular Biologist at Myriad Genetics from 2013 to 2016 and included a research fellowship at Brigham Young University from 2010 to 2012. Saroj holds an MBA in Health Care Administration from Western Governors University and a Bachelor of Science in Genetics and Biotechnology from Brigham Young University.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.